Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948865987> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2948865987 endingPage "OR" @default.
- W2948865987 startingPage "151" @default.
- W2948865987 abstract "In a recent study (STAT, NCT03143816), patients with type 1 diabetes mellitus (T1DM) treated with Technosphere Insulin (TI) demonstrated better early postprandial glucose (PPG) control than those on subcutaneous (SC) insulin aspart. The average daily dose of TI in patients who took TI as directed in the protocol was twice that of aspart (40.5 vs. 20.6 units). Despite the higher dose, the TI group experienced less time in hypoglycemia than the aspart group. These results prompted a retrospective analysis of mixed-meal tolerance tests (MMTTs) conducted in T1DM to further evaluate the 2:1 dosing ratio. In study MKC-TI-009 (NCT00308308), patients with T1DM underwent 1 to 3 MMTTs. A total of 1326 PPG profiles were evaluable: 674 MMTTs from 261 patients on SC aspart and 652 MMTTs from 264 patients on TI. On average, the area under the PPG excursion curve (PPGE AUC) decreased with increasing dose, and the mean (SE) ratio of the aspart slope to the TI slope was 2.1 (0.3), consistent with the results of STAT. This was confirmed when doses of TI 8, 16, and 24 units were compared with mean (SE) aspart doses of 4 (1), 8 (1), and 12 (1) units, respectively (Figure). The PPGE curves confirm the earlier onset and shorter duration of TI, while the tendency to drop below baseline in the late postprandial period reflects the longer duration of action of SC aspart. The timing of hypoglycemia (levels 1 and 2) follows the pattern of PPGEs. Disclosure M.L. Grant: Employee; Self; MannKind Corporation. Stock/Shareholder; Self; MannKind Corporation. F. Pompilio: Employee; Self; MannKind Corporation. Stock/Shareholder; Self; Amgen Inc., MannKind Corporation. G. Sharma: Employee; Self; MannKind Corporation. J.A. Krueger: Employee; Self; Eli Lilly and Company, MannKind Corporation. Stock/Shareholder; Self; Eli Lilly and Company. D.M. Kendall: Employee; Spouse/Partner; Amgen Inc. Employee; Self; MannKind Corporation. Stock/Shareholder; Self; MannKind Corporation. N. Zaveri: Employee; Self; MannKind Corporation. Stock/Shareholder; Self; Becton, Dickinson and Company. Funding MannKind Corporation" @default.
- W2948865987 created "2019-06-14" @default.
- W2948865987 creator A5013350892 @default.
- W2948865987 creator A5016676904 @default.
- W2948865987 creator A5034912281 @default.
- W2948865987 creator A5054378679 @default.
- W2948865987 creator A5085189729 @default.
- W2948865987 creator A5091464668 @default.
- W2948865987 date "2019-06-01" @default.
- W2948865987 modified "2023-09-24" @default.
- W2948865987 title "151-OR: Technosphere Insulin Provides Better Early Postprandial Glucose Control than Subcutaneous Rapid-Acting Analog" @default.
- W2948865987 doi "https://doi.org/10.2337/db19-151-or" @default.
- W2948865987 hasPublicationYear "2019" @default.
- W2948865987 type Work @default.
- W2948865987 sameAs 2948865987 @default.
- W2948865987 citedByCount "0" @default.
- W2948865987 crossrefType "journal-article" @default.
- W2948865987 hasAuthorship W2948865987A5013350892 @default.
- W2948865987 hasAuthorship W2948865987A5016676904 @default.
- W2948865987 hasAuthorship W2948865987A5034912281 @default.
- W2948865987 hasAuthorship W2948865987A5054378679 @default.
- W2948865987 hasAuthorship W2948865987A5085189729 @default.
- W2948865987 hasAuthorship W2948865987A5091464668 @default.
- W2948865987 hasConcept C126322002 @default.
- W2948865987 hasConcept C134018914 @default.
- W2948865987 hasConcept C2776390293 @default.
- W2948865987 hasConcept C2776664568 @default.
- W2948865987 hasConcept C2778199505 @default.
- W2948865987 hasConcept C2779306644 @default.
- W2948865987 hasConcept C3019948211 @default.
- W2948865987 hasConcept C555293320 @default.
- W2948865987 hasConcept C71924100 @default.
- W2948865987 hasConcept C98274493 @default.
- W2948865987 hasConceptScore W2948865987C126322002 @default.
- W2948865987 hasConceptScore W2948865987C134018914 @default.
- W2948865987 hasConceptScore W2948865987C2776390293 @default.
- W2948865987 hasConceptScore W2948865987C2776664568 @default.
- W2948865987 hasConceptScore W2948865987C2778199505 @default.
- W2948865987 hasConceptScore W2948865987C2779306644 @default.
- W2948865987 hasConceptScore W2948865987C3019948211 @default.
- W2948865987 hasConceptScore W2948865987C555293320 @default.
- W2948865987 hasConceptScore W2948865987C71924100 @default.
- W2948865987 hasConceptScore W2948865987C98274493 @default.
- W2948865987 hasIssue "Supplement 1" @default.
- W2948865987 hasLocation W29488659871 @default.
- W2948865987 hasOpenAccess W2948865987 @default.
- W2948865987 hasPrimaryLocation W29488659871 @default.
- W2948865987 hasRelatedWork W1983641721 @default.
- W2948865987 hasRelatedWork W2029699674 @default.
- W2948865987 hasRelatedWork W2045145511 @default.
- W2948865987 hasRelatedWork W2064185418 @default.
- W2948865987 hasRelatedWork W2080135029 @default.
- W2948865987 hasRelatedWork W2089449544 @default.
- W2948865987 hasRelatedWork W2129737421 @default.
- W2948865987 hasRelatedWork W2159000141 @default.
- W2948865987 hasRelatedWork W2594630750 @default.
- W2948865987 hasRelatedWork W2758620209 @default.
- W2948865987 hasVolume "68" @default.
- W2948865987 isParatext "false" @default.
- W2948865987 isRetracted "false" @default.
- W2948865987 magId "2948865987" @default.
- W2948865987 workType "article" @default.